Experts assess role of therapists in psychedelic‐assisted therapy

Nearly two dozen experts have issued a report highlighting the essential role of therapists in psychedelic-assisted therapy, amid a surge of research, media coverage, and investment aimed at gaining FDA approval for drugs like psilocybin. The report emphasizes that the therapeutic context and the therapist's involvement are critical to the process, not merely the drug itself.

Study at a glance

Abstract

Acknowledging the barrage of research, media attention and capital investment focused on psychedelic compounds and the race to reach U.S. Food and Drug Administration (FDA) approval for such currently illegal drugs as psilocybin, nearly two dozen experts have weighed in on a new report that, among other things, calls attention to the critical role they said therapists play in the psychedelic‐assisted therapy process.